Back

Variant-specific drug responses in FH: an ex vivo pilot study

13 June 2026 (12:08 - 12:11)
Organised by: Logo
Seminar Presentation Part of: Module B: Mentoring & how-to sessions - Poster rapid fire session 4 Basic Science, Other Premium Access Basic Science Course 2026 ESC Fund

About the speaker

Photo
Mr Rafael Graca

National Health Institute Doutor Ricardo Jorge, IP, Lisbon (Portugal)

9 More presentations in this session

Presentation thumbnail
Investigating oxpl-mediated vascular inflammation in humanized Lp(a) transgenic mice: a preclinical study toward novel therapeutic strategies
Mr V. Antoniou (Athens, GR)
Video
Presentation thumbnail
Transcriptomic analysis of mRNA in mouse model of chronic cigarette smoke-induced endothelial dysfunction treated with recombinant angiotensin-converting enzyme 2
Mr H. Hermawan (Surabaya, ID)
Video
Presentation thumbnail
Ruxolitinib attenuates cardio-renal inflammation via JAK-STAT and CaMKII signaling in hypertension
Ms M. Kiessling (Graz, AT)
Video
Presentation thumbnail
Role and mechanisms of the J1 gene in pulmonary arterial hypertension
Miss J. Ma (Guangzhou, CN)
Video
Presentation thumbnail
Unexpected cardioprotection in doxorubicin-treated mice during sepsis: Dennd4a-Rab10 axis as a potential mediator
Miss K. Markandran (Singapore, SG)
Video

Access the full session

Session thumbnail
Module B: Mentoring & how-to sessions - Poster rapid fire session 4

The Event

Event poster

Basic Science Course 2026

13 June 2026 12:08 CET
You may be interested in
thumbnail
Webinar
Molecular genetics of familial hypercholesterolemia (FH)
27 February 2023
thumbnail
Seminar Presentation
Functional characterization of LDLR variants associated with familial hypercholesterolemia
13 June 2026
thumbnail
Congress Session
Novel mechanisms for insights into atherosclerosis
26 August 2023
thumbnail
Congress Presentation
Platelet-Derived-Growth-Factor-Receptor-beta (PDGFB) and atherosclerotic cardiovascular disease presentation in genetically diagnosed familial hypercholesterolemia
31 August 2025

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources